Dudediligence.

Lifecore Biomedical, Inc

LFCRNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

37.7M

on 2026-06-30, from 30.6M on 2024-05-31 10-Q ↗

10M20M30M40MMay2024AugNovFeb2025MaySepDecMar2026Jun

Newest

$150.0M

S-3 of 2025-09-23. 1 prospectus supplement filed under it since. S-3 ↗

8 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-05 is not read yet.

Cash

$17.2M

Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-Q ↗

Raised: 11 of its filings are not read yet.